- The company has developed and brought to market a pediatric NeuroCap
- EEG testing in pediatrics may help diagnose autism, one of the fastest-growing developmental disorders in the US, and provide better treatment for pediatric patients with epilepsy
- COVID-19 made the process challenging but the team completed their task on time despite no in-person contact and the process coming to a halt twice due to shutdowns
Brain Scientific (OTCQB: BRSF), a health care company on a mission to modernize brain diagnostics with cutting-edge technologies, has developed and brought to market a pediatric-specific disposable EEG cap. The pediatric NeuroCap may aid in diagnosing autism and providing much needed information in treating pediatric epilepsy.
Autism is difficult to diagnose, yet the earlier it is discovered, the better the possibility of preventing some of the behaviors. A study published in the Scientific Reports Journal stated that EEGs can be used to accurately predict or rule out autism in children as young as three months (https://ibn.fm/t3KJq). One in fifty-nine children is diagnosed with autism by the time they are eight years old. It is one of the fastest-growing developmental disorders in the US, and the lifetime costs range anywhere from $1.4 to $2.2 million. (https://ibn.fm/XTPYG).
The CDC reports that there are approximately 470,000 children in the US with active epilepsy (https://ibn.fm/bs0Cv). Epilepsy does not present itself the same in every patient because there are many causes as well as many different types of seizures. This can make diagnosis challenging and EEGs are used in a supportive role combined with history, examinations and other tests (https://ibn.fm/Ja4Si).
When diagnosing children, the challenge comes in using ill-fitting bulky medical equipment designed for adults. The supply and availability of EEG testing in pediatrics are simply limited. Or it was until Brain Scientific decided to fill the gap and make easy-to-use disposable headsets for children and teens.
According to an article in Today’s Medical Developments (https://ibn.fm/CniU1), the team first approached the task intending to take the existing NeuroCap shrink it down to fit children and teens while also shortening the testing time from 30 minutes to 10 minutes. The process proved more challenging than expected in large part due to the pandemic.
Unable to meet in person, the team brainstormed through video conferencing and provided manufacturing instructions in pain-stacking detail. The manufacturer and one of the suppliers were forced to shut down at different times, both of which brought the process to a temporary halt.
Still, the team pushed forward, ensuring the timing was right, and they were the first to bring this product to the market. BRSF achieved the goal of creating a comfortable design in miniature and faster test results making the NeuroCap the perfect solution for pediatrics.
For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.